BioPharma
13 May, 2026 | Wednesday | News
Curocell And ProBio Achieve Korean Milestone With Approval Of Next Generation CAR T Therapy Anbal cel
Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene therapies, ProBio Inc. and Curocell have achieved a signi...
Lab
14 May, 2026 | Thursday | News
Isomorphic Labs Raises $2.1 Billion To Scale AI Driven Drug Discovery Platform
Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and develop...
BioTech
14 May, 2026 | Thursday | News
GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows
New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a ne...
Contract Services
06 May, 2026 | Wednesday | News
VectorBuilder Secures European Patent For MiniVec Plasmid System Advancing Genetic Medicine Development
Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines VectorBuilder, a global leader in gene delivery technologies and CDMO services, ann...
Consumer Health
18 May, 2026 | Monday | News
Singapore Post Limited And Fullerton Healthcare Group Private Limited Partner To Strengthen Community Healthcare Delivery Infrastructure
Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a rob...
Medtech
18 May, 2026 | Monday | News
Singapore Post Limited And Fullerton Healthcare Group Private Limited Partner To Strengthen Community Healthcare Delivery Infrastructure
Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a rob...
Cell & Gene
13 May, 2026 | Wednesday | News
Porton Advanced And Dark Horse Consulting Group Form Strategic Alliance To Accelerate Global Cell And Gene Therapy Translation
Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products (ATMPs), and Dark Horse Consulting Group ("DHCG" or "the Group"), a lead...
White Paper
24 April, 2026 | Friday | Analysis
Engineering Precision In Chromatography From Development To Commercial Scale
Product Spot Light
07 May, 2026 | Thursday | News
Ribbon Bio Launches Cell Free DNA Platform And In House MiroMine Kit To Expand Access To Complex Synthetic DNA
Premium Article
14 April, 2026 | Tuesday | Opinion
Can AI close the MSK inequality gap? Improving access to musculoskeletal care in the UK
Bio Invest
18 May, 2026 | Monday | News
NinaMED Pty Ltd Launches With US$13.75 Million Financing To Advance Non Invasive OAB Therapy
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
